ASSESSMENT OF PROGRESS TOWARDS 2014 STRATEGIC PLAN ASPIRATIONS TB CORE INDICATORS AS OUTLINED IN M&E PLAN
IMPACT INDICATORS Indicator NameTarget by 2014Actual by Dec 2012 Comment on likelihood of achievement Program Impact TB Incidence1365/100 0001320/100 000 Very likely however, given the declining notifications the relevancy of the incidence rate is weakened. TB Prevalence746/100 000854/100 000 Less likely though the variance is within margin TB Mortality29/100 00053/100 000 Less likely though the variance is within margin
OUTCOME INDICATORS Indicator NameTarget by 2014Actual by Dec 2012 Comment on likelihood of achievement Program Outcome TB Treatment Success82%73% likely to be achieved if current gains are sustained and strengthened TB Case Detection (All)100%53%Will not be met. TB Case Notification Rate 1149/100 000717/100 000 Will not be met however, the notifications declined when least expected hence the variance
OUTPUT INDICATORS Retreatment TB cases12%11% New Pulmonary TB SND15%20% New Pulmonary TB SS+40%33% Sputum Conversion Rate (New)75%63% Sputum Conversion Rate (Retreatment) 60%50% Cure Rate of New TB cases60%48% Cure Rate of Re-treatments35%34% Treatment Completion rate22%25% Treatment Failure rate5%8% Default rate7%5% Smear Positivity rate40%37% Retreatment Failure rate (Chronic TB) 15%10%
OUTPUT INDICATORS % HCFs initiating TB Treatment 67/139 (48%)73/139 (53%) % Health Staff trained in TB 70%No reliable data TB Control is among Stated Priorities 10% increase for TB Budget Data still being validated Availability of TB Program Manual No target Manual available & Partly distributed Availability of TB Program Strategic Plan & Budget No targetYes
OUTPUT INDICATORS Diagnosis & Lab TB Microscopy coverage (Ratio)No target1/50 000 TB Culture services coverage ratioNo target1/1 000 000 % Laboratories performing regular EQA90%100% Private Public Mix % Private HCFs submitting TB Notifications15%11% % Patients detected in the private sector11%4% Drug Management Existence of Buffer Stock at Central & Peripheral levels No targetNo reliable data Accuracy of Stock Records for anti-TB drugs80%No reliable data % HCFs reporting no stock-out of anti-TB drugs 100%
OUTPUT INDICATORS TB/HIV % PLWHA Screened for TB100%No reliable Denominator % Registered TB patients who received HIV testing 90%92% HIV Ser0-prevalence among TB patients75%80% % registered TB/HIV Patients started on ART50%66% Supervision & Patient Support % of facilities receiving periodic supportive supervision from NTCP 80%22/73 (30%) % Registered TB Patients receiving direct observation of treatment (D.O.T.) 85%4025/7741 (52%) % MDR-TB Patients receiving DOT97%113/220 (51%) % Laboratory Confirmed MDR-TB cases33%220/2437 (9%) % Laboratory Confirmed MDR-TB cases enrolled on second line treatment 86%185/220 (84%)
Quick Reflections… WHERE TO FROM HERE…. - What policy directions & strategies are relevant?